| |
|
|
|
KemPharm Inc.  
|
|
0.253 -0.01 (-0.04%) |
07-09 15:59 |
|
Open: |
0.259 |
Pre close: |
0.2633 |
Target:
|
0.36
|
|
High: |
0.279 |
Low: |
0.24 |
Resistance:
|
0.31
0.36
|
|
Volume: |
640,792 |
Market Cap: |
17M |
Support:
|
0.19
0.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.23
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
0.20 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.26  |
Stochastic Oscillator |
%K(14,3):
|
86.54 |
|
MA(250): |
0.58 |
%D(3): |
91.13 |
|
Average Volume(K) |
3-Month: |
296148
|
52-Week |
High:
|
1.85 |
|
10-Days: |
124896 |
Low: |
0.12 |
|
RSI |
RSI(14):
|
66.14 |
Change(%): |
-82.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.514 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
65.76 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-51.8 |
Shares Float (M) |
56.83 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.46 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.76 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.150 |
Shares Short (K) |
636 |
|
Book Value (p.s.) |
-1.210 |
EBITDA (p.s.) |
-0.177 |
P/E |
-0.53 |
|
Sales Per Share |
0.227 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-0.22 |
|
Profit Margin |
-120.48 |
Operating Cash Flow
(M) |
-14.69 |
P/S |
1.19 |
|
Operating Margin |
-79.80 |
Levered Free Cash Flow
(M) |
-8.30 |
P/CF |
-1.21 |
|
|
|
|
|
|
